Humana Inc. HUM recently announced its partnership with Premier Independent Physicians (PIP) to provide a coordinated and enriched patient experience for Humana Medicare Advantage Members residing in Dallas-Fort Worth Metro. With this deal, Humana’s Medicare Advantage Health Maintenance Organization (HMO) and Preferred Provider Organization (PPO) plan members based in Cook, Collin, Dallas, Denton, Ellis, Johnson, Lamar, Palo Pinto, Tarrant and Wise counties will be allowed an access to PIP’s numerous physicians and facilities in the Dallas-Fort Worth Metro.

Moreover, the partnership would make the same facilities available to the company’s Dual Eligible Special Needs Plan members in Collin, Dallas, Denton, Ellis, Johnson, Tarrant and Wise counties.

This deal supplements Humana’s commitment to offer its members a value-based and patient-centric care. Members can spend more time with health professionals and get personalized care that suits their requirements and matches healthy situations. Patients with chronic illnesses are paid immediate attention to prevent health complications. The value-based care also resorts to technology such as data analytics that helps team members coordinate in a better way.

PIP offers a model for care in north Texas and Southern Oklahoma that mainly focuses on primary care physicians plus operational, technology and practice management. This enables PIP to free primary care physicians for facilitating better patient care. The model solely concentrates on bringing like-minded hospitals together to provide an uninterrupted care, aiming for enhancing the quality of life.

Humana expects that this tie-up would help it dispense the best healthcare services to its Dallas-Fort Worth Medicare Advantage members, to improve their well-being . The company has an extensive value-based care presence. Total Medicare Advantage membership of the company is more than 3.5 million.

Recently, the company also formed an alliance with Kansas City to provide an advanced integrated care. Moreover, it has teamed up with Heritage Provider Network and Vancouver Clinic Team to enrich patient care for Medicare Advantage members. Humana’s Medicare business has been delivering a strong performance from the past many quarters. Evidently, a 5.5% average growth rate for total Retail Medicare membership has been witnessed in the last four years. Also, the same rose 8.5% year over year for the first nine months of 2018.

Shares of Zacks Rank #2 (Buy) company have rallied 35.8%, outperforming the industry's increase of 25.1%.

Other Stocks to Consider

Investors looking for some other top-ranked stocks may also consider Anthem, Inc. ANTM, Molina Healthcare, Inc. MOH, and UnitedHealth Group Incorporated UNH for portfolio boost.

Operating as a health benefits company in the United States, Anthem, Inc. pulled of an encouraging earnings surprise of 5.11% over the preceding four reported quarters. It sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Molina provides Medicaid-related solutions to low-income families and individuals. It assists state agencies to carry out Medicaid program’s administration work in the United States. It has a Zacks Rank of 1 and managed to deliver the average four-quarter beat of 82.55%.

UnitedHealth operates as a diversified health care company in the United States. The stock holds a Zacks Rank of 2 and came up with a positive surprise of 3.67%.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
 
Humana Inc. (HUM) : Free Stock Analysis Report
 
Molina Healthcare, Inc (MOH) : Free Stock Analysis Report
 
Anthem, Inc. (ANTM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research